Fibroblast Growth Factor 23 is Associated with Subclinical Cerebrovascular Damage: the Northern Manhattan Study (NOMAS)

BACKGROUND AND PURPOSE: Elevated fibroblast growth factor 23 (FGF23) regulates phosphate homeostasis and is linked with mortality, cardiovascular events, and stroke. However, the role of FGF23 as a risk factor for subclinical cerebrovascular damage (SCVD) is unclear. METHODS: We used multivariable l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stroke
Autors principals: Wright, Clinton B., Shah, Nirav H., Mendez, Armando J., DeRosa, Janet T., Yoshita, Mitsuhiro, Elkind, Mitchell S. V., Sacco, Ralph L., DeCarli, Charles, Rundek, Tatjana, Silverberg, Shonni, Dong, Chuanhui, Wolf, Myles
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4811730/
https://ncbi.nlm.nih.gov/pubmed/26956260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.115.012379
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars